Pharmaceutical Technology
MAY 9, 2024
Clinical trials are growing across Africa as the immense potential of the continent starts to be realised. Sponsors and CROs are tapping into the unsaturated patient pools, more diverse populations, and competitive operations costs.
Bio Pharma Dive
MAY 9, 2024
The company is discontinuing an array of early drug programs, including several in oncology, as it prioritizes investment in six late-stage assets.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MAY 9, 2024
Anixa Biosciences has expanded its partnership with Cleveland Clinic to develop additional vaccines for cancers.
Bio Pharma Dive
MAY 9, 2024
The deal with Metaphore Biotechnologies is the third to emerge from a Flagship alliance that’s meant to boost the Danish drugmaker’s pipeline of weight loss medicines.
AuroBlog - Aurous Healthcare Clinical Trials blog
MAY 9, 2024
Virus containing droplets were suspended in the CELEBS experimental device for different durations before infectivity was tested. (Allen Haddrell/University of Bristol) Keeping CO2 levels low reduces infectious airborne viral loads, new research suggests.
Bio Pharma Dive
MAY 9, 2024
The deal gives the company milestone payments and royalties to a medicine, frexalimab, that Sanofi licensed from biotech ImmuNext and expects to be a future blockbuster.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
MAY 9, 2024
Rakovina has expanded research collaborations with Pharma Inventor and the University of British Columbia to identify novel drug candidates.
pharmaphorum
MAY 9, 2024
A UK report has said that inflation and geopolitical instability have led to a “dramatic drop” in investment in smaller companies developing new medicines, with a knock-on effect on the entire life sciences industry.
Pharmaceutical Technology
MAY 9, 2024
Workforce optimisation, R&D prioritisation and technology investments are on Takeda’s agenda.
pharmaphorum
MAY 9, 2024
A new metric developed by Phesi can predict the burden that clinical trials will impose on patients, allowing amendments that can improve the design, efficiency and cost
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
MAY 9, 2024
Marinus expects to share data from the Phase III RAISE trial of IV ganaxolone for the treatment of status epilepticus later in the summer.
pharmaphorum
MAY 9, 2024
How have drug container closure testing methods changed over time? This post explores the history and development of techniques to evaluate container integrity.
Pharmaceutical Technology
MAY 9, 2024
Sobi gains approval for an indication extension from the European Commission for Aspaveli for adults with PNH who have haemolytic anaemia.
Pharmaceutical Commerce
MAY 9, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Cathy O'Brien, VP of Sales, UPS Healthcare discusses her masterclass on delivering agility in supply chains by building a multimodal cold chain network while also reducing risks at LogiPharma Europe 2024.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
MAY 9, 2024
A research project between DMU and the University of Surrey received a grant to help reduce costs for companies in developing medicines.
XTalks
MAY 9, 2024
This episode of the Xtalks Food Podcast features an interview with Cally Edgren, a PFAS expert and the Senior Director of Sustainability at Assent, a leader in supply chain sustainability management solutions. Cally starts off by explaining what PFAS chemicals are and why they are so prevalent in the food industry. She delves into the details of a federal PFAS ban that was proposed in April and how it would impact businesses if passed.
Pharmaceutical Technology
MAY 9, 2024
The GHIT Fund announced an investment of Y1.64bn ($10.8m) in four new projects aimed at developing drugs to treat malaria and NTDs.
pharmaphorum
MAY 9, 2024
Google DeepMind and Isomorphic Labs' newly launched AlphaFold 3 extends the power of the AI model to 'all life’s molecules'
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
MAY 9, 2024
Acumen Pharmaceuticals has dosed the first patient in the ALTITUDE-AD Phase II trial for its lead drug sabirnetug (ACU193).
Pharma Times
MAY 9, 2024
Anticancer drugs will be responsible for 90% of nearly 612,000 predicted US cancer deaths in 2024
Pharmaceutical Technology
MAY 9, 2024
The Danish biotech, Commit Biologics, will focus on developing antibody therapies to treat cancer and autoimmune diseases.
BioSpace
MAY 9, 2024
Launched in 2021, the public-private consortium on Wednesday updated ASGCT attendees on its efforts to bring adeno-associated virus gene therapies to more rare disease patients.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharma Times
MAY 9, 2024
The subtype accounts for 20% of all T-cell leukaemias, a rare form of blood cancer which produces too many abnormal T-cells
BioSpace
MAY 9, 2024
As competition with Eli Lilly heats up, Novo Nordisk has partnered with Flagship’s Metaphore Biotechnologies to take biomimicry approach to GLP-1s.
Fierce Pharma
MAY 9, 2024
Five months out from their twin FDA approvals in sickle cell disease (SCD), who’s winning the race to treat patients with their respective gene therapies—bluebird bio or partners Vertex Pharmaceuti | Five months out from their twin FDA approvals in sickle cell disease (SCD), who’s winning the race to treat patients with their respective gene therapies—bluebird bio or partners Vertex Pharmaceuticals and CRISPR Therapeutics?
BioSpace
MAY 9, 2024
After a combination with Eisai’s Lenvima failed to improve survival in advanced disease in December, adjuvant Keytruda plus chemotherapy missed the mark in newly diagnosed, high-risk patients.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Fierce Pharma
MAY 9, 2024
After telegraphing more than a hundred potential layoffs in March in connection with plans to stop construction of a massive Seagen facility, Pfizer is plowing ahead with efforts to streamline its | Pfizer has proposed another round of staff reductions and role changes at legacy Seagen, this time hitting Seagen’s European headquarters in Switzerland, where 74 positions could be up for the chop.
Outsourcing Pharma
MAY 9, 2024
A collaborative report released today (May 9) by Medicines Discovery Catapult (MDC), sheds light on the challenges facing the life sciences sector amidst recent economic turbulence.
Fierce Pharma
MAY 9, 2024
While Merck & Co.’s Keytruda already boasts a pair of approvals to treat certain forms of endometrial cancer, a recent effort to prove the PD-1 inhibitor’s worth as a post-surgery add-on therap | While Merck & Co.’s Keytruda already boasts a pair of approvals to treat certain forms of endometrial cancer, a recent effort to prove the PD-1 inhibitor’s worth as a post-surgery add-on therapy in newly diagnosed patients has fallen short.
BioSpace
MAY 9, 2024
Takeda saw a 57% drop in profit in its 2023 fiscal year and has lowered its outlook for the coming fiscal year, mostly driven by increasing generic competition for its ADHD treatment Vyvanse.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
130 
Let's personalize your content